Gemina Laboratories Ltd.
GLAB
Rank in Stocks
#35736
Gemina Laboratories Ltd. is a Canadian biotechnology company dedicated to the... Gemina Laboratories Ltd. is a Canadian biotechnology company dedicated to the research, development, and commercialization of in-vitro diagnostics. The firm invents innovative surface functionalization chemistries for identifying pathogens and biomarkers. Among its current projects, Gemina is advancing the POC Antigen COVID test, a rapid, point-of-care lateral flow assay strip specifically designed to detect active COVID-19 infections. The company maintains its headquarters in Vancouver, Canada.
Share Price
$0.04377166
Last synced: 2026-02-05
Market Cap
$3.35M
Change (1 day)
-0.30%
Change (1 year)
-81.04%
Country
CA
Trade Gemina Laboratories Ltd. (GLAB)
Category
Healthcare
EPS for Gemina Laboratories Ltd. (GLAB)
EPS as of 2026 TTM: 0
According to Gemina Laboratories Ltd. latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for Gemina Laboratories Ltd. from 2026 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| Not enough data for the provided dates. | ||
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $17.32 | - |
US
|
|
| $-7.98 | - |
US
|
|
| $-5.29 | - |
AU
|
|
| - | - |
CH
|
|
| $27.74 | - |
NL
|
